Related Experiment Video
Updated: Apr 3, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
914
Nuclear, not cytoplasmic, PKR maneuvers in AML.
Motohiko Oshima1, Atsushi Iwama1
1CHIBA UNIVERSITY.
Blood
|September 26, 2015
Summary
Researchers discovered a new role for double-stranded RNA-activated protein kinase (PKR) in acute myeloid leukemia (AML). Increased nuclear PKR drives genomic instability and predicts poor outcomes, highlighting it as a potential therapeutic target for leukemia.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of double-stranded RNA-activated protein kinase (PKR) in cancer is complex and not fully understood.
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with significant unmet therapeutic needs.
Purpose of the Study:
- To investigate the nuclear function of PKR in the pathogenesis of AML.
- To determine the correlation between PKR levels, genomic instability, and clinical outcomes in AML patients and a relevant mouse model.
Main Methods:
- Analysis of PKR expression in AML patient samples.
- Assessment of genomic instability in relation to PKR levels.
- Evaluation of PKR function in a mouse model of myelodysplastic syndrome (MDS) and leukemia.
Main Results:
- A novel nuclear function of PKR was identified in AML pathogenesis.
- Increased nuclear PKR was found to promote genomic instability.
- Elevated PKR levels were associated with inferior clinical outcomes in both AML and a mouse model.
Conclusions:
- Nuclear PKR possesses an oncogenic function in AML.
- PKR represents a potential therapeutic target for preventing leukemia progression and relapse.
- Targeting nuclear PKR may improve clinical outcomes in patients with AML and related disorders.
Related Concept Videos
01:07MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
01:22Amplifying Signals via Enzymatic Cascade
19.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.4K
01:26Receptor Tyrosine Kinases
20.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.8K
01:20The JAK-STAT Signaling Pathway
13.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.9K
01:19Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
01:22PI3K/mTOR/AKT Signaling Pathway
6.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.4K